The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Chorionic Gonadotropin (HCG) Market Research Report 2025

Global Human Chorionic Gonadotropin (HCG) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1971741

No of Pages : 96

Ask Your Query

Synopsis

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

The global Human Chorionic Gonadotropin (HCG) market was valued at US$ 745.2 million in 2023 and is anticipated to reach US$ 1173.2 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.

The growth of the human chorionic gonadotropin (HCG) market is attributed to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment. Hypogonadism, for example, is characterized by low serum testosterone concentration, which is followed by a number of clinical features such as erectile dysfunction (ED), poor morning erections, low libido, memory loss, physical decline in strength and health, difficulty concentrating, and depression.According to the study published by BMC Endocrine Disorders in July 2021, erectile dysfunction was found to be prevalent in 72.2% of people globally in 2021. Furthermore, according to the CDC update in March 2022, about 1 in 5 (22%) couples in which the woman is 30-39 have problems conceiving their first child, compared to about 1 in 8 (13%) couples in which the woman is younger than 30. Age-related fertility loss is mostly caused by deteriorating egg quality. Older women also have fewer remaining eggs and are more likely to have health issues that can affect fertility. Aging also increases a woman’s chances of miscarriage and of having a child with a genetic abnormality. Therefore, the high burden of infertility is also raising the demand for effective treatments such as human chorionic gonadotropin (HCG) hormones, which is fueling the market's growth.

This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotropin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotropin (HCG).

Report Scope

The Human Chorionic Gonadotropin (HCG) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Chorionic Gonadotropin (HCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Chorionic Gonadotropin (HCG) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • EMD Serono, Inc
  • Ferring B.V
  • Merck & Co., Inc
  • Bristol Myers Squibb Company
  • Fresenius Kabi AG
  • Scripps Laboratories
  • Leebio
  • Kamiya Biomedical Company
  • Sanzyme
  • Cigna
  • LUPIN
  • Sun Pharmaceutical Industries Ltd
  • Serum Institute of India Pvt. Ltd
  • VHB Medi Sciences Limited
  • Zydus Lifesciences Ltd
  • Corona Remedies Pvt. Ltd.

Segment by Type

  • Natural Source Extraction
  • Recombinant DNA Technology

Segment by Application

  • Female Infertility Treatment
  • Oligospermic Treatment
  • Cryptorchidism Treatment
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Chorionic Gonadotropin (HCG) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Natural Source Extraction
1.2.3 Recombinant DNA Technology
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Female Infertility Treatment
1.3.3 Oligospermic Treatment
1.3.4 Cryptorchidism Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Chorionic Gonadotropin (HCG) Market Perspective (2019-2030)
2.2 Human Chorionic Gonadotropin (HCG) Growth Trends by Region
2.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Chorionic Gonadotropin (HCG) Historic Market Size by Region (2019-2024)
2.2.3 Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Region (2025-2030)
2.3 Human Chorionic Gonadotropin (HCG) Market Dynamics
2.3.1 Human Chorionic Gonadotropin (HCG) Industry Trends
2.3.2 Human Chorionic Gonadotropin (HCG) Market Drivers
2.3.3 Human Chorionic Gonadotropin (HCG) Market Challenges
2.3.4 Human Chorionic Gonadotropin (HCG) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotropin (HCG) Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotropin (HCG) Players by Revenue (2019-2024)
3.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Players (2019-2024)
3.2 Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Chorionic Gonadotropin (HCG) Revenue
3.4 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotropin (HCG) Revenue in 2023
3.5 Human Chorionic Gonadotropin (HCG) Key Players Head office and Area Served
3.6 Key Players Human Chorionic Gonadotropin (HCG) Product Solution and Service
3.7 Date of Enter into Human Chorionic Gonadotropin (HCG) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Chorionic Gonadotropin (HCG) Breakdown Data by Type
4.1 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Type (2019-2024)
4.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Type (2025-2030)
5 Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
5.1 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Application (2019-2024)
5.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Chorionic Gonadotropin (HCG) Market Size (2019-2030)
6.2 North America Human Chorionic Gonadotropin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024)
6.4 North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotropin (HCG) Market Size (2019-2030)
7.2 Europe Human Chorionic Gonadotropin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024)
7.4 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size (2019-2030)
8.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size (2019-2030)
9.2 Latin America Human Chorionic Gonadotropin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024)
9.4 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size (2019-2030)
10.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EMD Serono, Inc
11.1.1 EMD Serono, Inc Company Detail
11.1.2 EMD Serono, Inc Business Overview
11.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Introduction
11.1.4 EMD Serono, Inc Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.1.5 EMD Serono, Inc Recent Development
11.2 Ferring B.V
11.2.1 Ferring B.V Company Detail
11.2.2 Ferring B.V Business Overview
11.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Introduction
11.2.4 Ferring B.V Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.2.5 Ferring B.V Recent Development
11.3 Merck & Co., Inc
11.3.1 Merck & Co., Inc Company Detail
11.3.2 Merck & Co., Inc Business Overview
11.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Introduction
11.3.4 Merck & Co., Inc Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.3.5 Merck & Co., Inc Recent Development
11.4 Bristol Myers Squibb Company
11.4.1 Bristol Myers Squibb Company Company Detail
11.4.2 Bristol Myers Squibb Company Business Overview
11.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Introduction
11.4.4 Bristol Myers Squibb Company Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.4.5 Bristol Myers Squibb Company Recent Development
11.5 Fresenius Kabi AG
11.5.1 Fresenius Kabi AG Company Detail
11.5.2 Fresenius Kabi AG Business Overview
11.5.3 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Introduction
11.5.4 Fresenius Kabi AG Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.5.5 Fresenius Kabi AG Recent Development
11.6 Scripps Laboratories
11.6.1 Scripps Laboratories Company Detail
11.6.2 Scripps Laboratories Business Overview
11.6.3 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Introduction
11.6.4 Scripps Laboratories Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.6.5 Scripps Laboratories Recent Development
11.7 Leebio
11.7.1 Leebio Company Detail
11.7.2 Leebio Business Overview
11.7.3 Leebio Human Chorionic Gonadotropin (HCG) Introduction
11.7.4 Leebio Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.7.5 Leebio Recent Development
11.8 Kamiya Biomedical Company
11.8.1 Kamiya Biomedical Company Company Detail
11.8.2 Kamiya Biomedical Company Business Overview
11.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Introduction
11.8.4 Kamiya Biomedical Company Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.8.5 Kamiya Biomedical Company Recent Development
11.9 Sanzyme
11.9.1 Sanzyme Company Detail
11.9.2 Sanzyme Business Overview
11.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Introduction
11.9.4 Sanzyme Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.9.5 Sanzyme Recent Development
11.10 Cigna
11.10.1 Cigna Company Detail
11.10.2 Cigna Business Overview
11.10.3 Cigna Human Chorionic Gonadotropin (HCG) Introduction
11.10.4 Cigna Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.10.5 Cigna Recent Development
11.11 LUPIN
11.11.1 LUPIN Company Detail
11.11.2 LUPIN Business Overview
11.11.3 LUPIN Human Chorionic Gonadotropin (HCG) Introduction
11.11.4 LUPIN Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.11.5 LUPIN Recent Development
11.12 Sun Pharmaceutical Industries Ltd
11.12.1 Sun Pharmaceutical Industries Ltd Company Detail
11.12.2 Sun Pharmaceutical Industries Ltd Business Overview
11.12.3 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Introduction
11.12.4 Sun Pharmaceutical Industries Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.12.5 Sun Pharmaceutical Industries Ltd Recent Development
11.13 Serum Institute of India Pvt. Ltd
11.13.1 Serum Institute of India Pvt. Ltd Company Detail
11.13.2 Serum Institute of India Pvt. Ltd Business Overview
11.13.3 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Introduction
11.13.4 Serum Institute of India Pvt. Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.13.5 Serum Institute of India Pvt. Ltd Recent Development
11.14 VHB Medi Sciences Limited
11.14.1 VHB Medi Sciences Limited Company Detail
11.14.2 VHB Medi Sciences Limited Business Overview
11.14.3 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Introduction
11.14.4 VHB Medi Sciences Limited Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.14.5 VHB Medi Sciences Limited Recent Development
11.15 Zydus Lifesciences Ltd
11.15.1 Zydus Lifesciences Ltd Company Detail
11.15.2 Zydus Lifesciences Ltd Business Overview
11.15.3 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Introduction
11.15.4 Zydus Lifesciences Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.15.5 Zydus Lifesciences Ltd Recent Development
11.16 Corona Remedies Pvt. Ltd.
11.16.1 Corona Remedies Pvt. Ltd. Company Detail
11.16.2 Corona Remedies Pvt. Ltd. Business Overview
11.16.3 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Introduction
11.16.4 Corona Remedies Pvt. Ltd. Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
11.16.5 Corona Remedies Pvt. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Natural Source Extraction
Table 3. Key Players of Recombinant DNA Technology
Table 4. Global Human Chorionic Gonadotropin (HCG) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Chorionic Gonadotropin (HCG) Market Share by Region (2019-2024)
Table 8. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Chorionic Gonadotropin (HCG) Market Share by Region (2025-2030)
Table 10. Human Chorionic Gonadotropin (HCG) Market Trends
Table 11. Human Chorionic Gonadotropin (HCG) Market Drivers
Table 12. Human Chorionic Gonadotropin (HCG) Market Challenges
Table 13. Human Chorionic Gonadotropin (HCG) Market Restraints
Table 14. Global Human Chorionic Gonadotropin (HCG) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Chorionic Gonadotropin (HCG) Market Share by Players (2019-2024)
Table 16. Global Top Human Chorionic Gonadotropin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2023)
Table 17. Ranking of Global Top Human Chorionic Gonadotropin (HCG) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotropin (HCG) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Chorionic Gonadotropin (HCG) Product Solution and Service
Table 21. Date of Enter into Human Chorionic Gonadotropin (HCG) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotropin (HCG) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2019-2024)
Table 25. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2025-2030)
Table 27. Global Human Chorionic Gonadotropin (HCG) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2019-2024)
Table 29. Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2025-2030)
Table 31. North America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 46. EMD Serono, Inc Company Detail
Table 47. EMD Serono, Inc Business Overview
Table 48. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product
Table 49. EMD Serono, Inc Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 50. EMD Serono, Inc Recent Development
Table 51. Ferring B.V Company Detail
Table 52. Ferring B.V Business Overview
Table 53. Ferring B.V Human Chorionic Gonadotropin (HCG) Product
Table 54. Ferring B.V Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 55. Ferring B.V Recent Development
Table 56. Merck & Co., Inc Company Detail
Table 57. Merck & Co., Inc Business Overview
Table 58. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product
Table 59. Merck & Co., Inc Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 60. Merck & Co., Inc Recent Development
Table 61. Bristol Myers Squibb Company Company Detail
Table 62. Bristol Myers Squibb Company Business Overview
Table 63. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product
Table 64. Bristol Myers Squibb Company Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 65. Bristol Myers Squibb Company Recent Development
Table 66. Fresenius Kabi AG Company Detail
Table 67. Fresenius Kabi AG Business Overview
Table 68. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product
Table 69. Fresenius Kabi AG Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 70. Fresenius Kabi AG Recent Development
Table 71. Scripps Laboratories Company Detail
Table 72. Scripps Laboratories Business Overview
Table 73. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product
Table 74. Scripps Laboratories Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 75. Scripps Laboratories Recent Development
Table 76. Leebio Company Detail
Table 77. Leebio Business Overview
Table 78. Leebio Human Chorionic Gonadotropin (HCG) Product
Table 79. Leebio Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 80. Leebio Recent Development
Table 81. Kamiya Biomedical Company Company Detail
Table 82. Kamiya Biomedical Company Business Overview
Table 83. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product
Table 84. Kamiya Biomedical Company Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 85. Kamiya Biomedical Company Recent Development
Table 86. Sanzyme Company Detail
Table 87. Sanzyme Business Overview
Table 88. Sanzyme Human Chorionic Gonadotropin (HCG) Product
Table 89. Sanzyme Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 90. Sanzyme Recent Development
Table 91. Cigna Company Detail
Table 92. Cigna Business Overview
Table 93. Cigna Human Chorionic Gonadotropin (HCG) Product
Table 94. Cigna Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 95. Cigna Recent Development
Table 96. LUPIN Company Detail
Table 97. LUPIN Business Overview
Table 98. LUPIN Human Chorionic Gonadotropin (HCG) Product
Table 99. LUPIN Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 100. LUPIN Recent Development
Table 101. Sun Pharmaceutical Industries Ltd Company Detail
Table 102. Sun Pharmaceutical Industries Ltd Business Overview
Table 103. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product
Table 104. Sun Pharmaceutical Industries Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 105. Sun Pharmaceutical Industries Ltd Recent Development
Table 106. Serum Institute of India Pvt. Ltd Company Detail
Table 107. Serum Institute of India Pvt. Ltd Business Overview
Table 108. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product
Table 109. Serum Institute of India Pvt. Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 110. Serum Institute of India Pvt. Ltd Recent Development
Table 111. VHB Medi Sciences Limited Company Detail
Table 112. VHB Medi Sciences Limited Business Overview
Table 113. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product
Table 114. VHB Medi Sciences Limited Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 115. VHB Medi Sciences Limited Recent Development
Table 116. Zydus Lifesciences Ltd Company Detail
Table 117. Zydus Lifesciences Ltd Business Overview
Table 118. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product
Table 119. Zydus Lifesciences Ltd Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 120. Zydus Lifesciences Ltd Recent Development
Table 121. Corona Remedies Pvt. Ltd. Company Detail
Table 122. Corona Remedies Pvt. Ltd. Business Overview
Table 123. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product
Table 124. Corona Remedies Pvt. Ltd. Revenue in Human Chorionic Gonadotropin (HCG) Business (2019-2024) & (US$ Million)
Table 125. Corona Remedies Pvt. Ltd. Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Chorionic Gonadotropin (HCG) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Chorionic Gonadotropin (HCG) Market Share by Type: 2023 VS 2030
Figure 3. Natural Source Extraction Features
Figure 4. Recombinant DNA Technology Features
Figure 5. Global Human Chorionic Gonadotropin (HCG) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Chorionic Gonadotropin (HCG) Market Share by Application: 2023 VS 2030
Figure 7. Female Infertility Treatment Case Studies
Figure 8. Oligospermic Treatment Case Studies
Figure 9. Cryptorchidism Treatment Case Studies
Figure 10. Others Case Studies
Figure 11. Human Chorionic Gonadotropin (HCG) Report Years Considered
Figure 12. Global Human Chorionic Gonadotropin (HCG) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Human Chorionic Gonadotropin (HCG) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Human Chorionic Gonadotropin (HCG) Market Share by Region: 2023 VS 2030
Figure 15. Global Human Chorionic Gonadotropin (HCG) Market Share by Players in 2023
Figure 16. Global Top Human Chorionic Gonadotropin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotropin (HCG) Revenue in 2023
Figure 18. North America Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Human Chorionic Gonadotropin (HCG) Market Share by Country (2019-2030)
Figure 20. United States Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Chorionic Gonadotropin (HCG) Market Share by Country (2019-2030)
Figure 24. Germany Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Share by Region (2019-2030)
Figure 32. China Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Chorionic Gonadotropin (HCG) Market Share by Country (2019-2030)
Figure 40. Mexico Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Share by Country (2019-2030)
Figure 44. Turkey Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Human Chorionic Gonadotropin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. EMD Serono, Inc Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 47. Ferring B.V Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 48. Merck & Co., Inc Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 49. Bristol Myers Squibb Company Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 50. Fresenius Kabi AG Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 51. Scripps Laboratories Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 52. Leebio Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 53. Kamiya Biomedical Company Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 54. Sanzyme Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 55. Cigna Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 56. LUPIN Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 57. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 58. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 59. VHB Medi Sciences Limited Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 60. Zydus Lifesciences Ltd Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 61. Corona Remedies Pvt. Ltd. Revenue Growth Rate in Human Chorionic Gonadotropin (HCG) Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock